Literature DB >> 17642985

Mother-to-child transmission and diagnosis of Toxoplasma gondii infection during pregnancy.

S Singh1.   

Abstract

Toxoplasmosis is caused by a coccidian parasite Toxoplasma gondii. It is world-wide in distribution and infects most of the vertebrates. The cat family animals (Felides) are its definitive host. The humans are infected either through contaminated food, water, transfusion of infected blood, organ transplantation or from mother-to-foetus through placenta. The prevalence of toxoplasmosis in Indian pregnant women is variably reported. However, the knowledge about this infection, its diagnosis and interpretation of test results is a major problem in the Indian context. Though Toxoplasma infection does not cause repeated fetal losses, this is the most common indication for investigation of toxoplasmosis in India. There are several diagnostic test kits available in Indian market, however, their quality is not assessed by most of the laboratories before they are procured. There is also no baseline data on the antibody titres in various subpopulations of India. This review is focused on various modes of transmission, prevalence data and its significance and interpretation of various antibody tests in pregnant mothers and in babies.

Entities:  

Year:  2003        PMID: 17642985

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  19 in total

1.  An unusual case of disseminated toxoplasmosis in a previously healthy pregnant patient: radiographic, CT, and MRI findings.

Authors:  Samir Paruthikunnan; Balasubramanyam Shankar; Rajagopal Kadavigere; Mukhyaprana Prabhu; Ramakrishna Narayanan; Harshwardhan Jain
Journal:  Jpn J Radiol       Date:  2014-08-24       Impact factor: 2.374

2.  Seroprevalence of Toxoplasma gondii in southern districts of Tamil Nadu using IgG-ELISA.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  J Parasit Dis       Date:  2012-03-13

3.  Evaluation of Pichia pastoris-expressed recombinant rhoptry protein 2 of Toxoplasma gondii for its application in diagnosis of toxoplasmosis.

Authors:  Phooi Yee Chang; Mun Yik Fong; Veeranoot Nissapatorn; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

4.  Prevalence of Serum Antibodies to TORCH Infection in and Around Varanasi, Northern India.

Authors:  M R Sen; B N Shukla; Banerjee Tuhina
Journal:  J Clin Diagn Res       Date:  2012-11

5.  Pantothenic acid biosynthesis in the parasite Toxoplasma gondii: a target for chemotherapy.

Authors:  Sarmad N Mageed; Fraser Cunningham; Alvin Wei Hung; Hernani Leonardo Silvestre; Shijun Wen; Tom L Blundell; Chris Abell; Glenn A McConkey
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

6.  Toxoplasmosis during pregnancy: a case report and review of the literature.

Authors:  C Giannoulis; B Zournatzi; A Giomisi; E Diza; I Tzafettas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

Review 7.  Development of Toxoplasma gondii vaccine: A global challenge.

Authors:  Ramesh Verma; Pardeep Khanna
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

Review 8.  Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy.

Authors:  Aref Teimouri; Sina Mohtasebi; Elham Kazemirad; Hossein Keshavarz
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

9.  Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a tertiary-care hospital of Andhra Pradesh, India.

Authors:  Munmun Das Sarkar; B Anuradha; Neelam Sharma; Rabindra Nath Roy
Journal:  J Health Popul Nutr       Date:  2012-03       Impact factor: 2.000

10.  Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk in an ethnically diverse population.

Authors:  Andrew Flatt; Nandini Shetty
Journal:  Eur J Public Health       Date:  2012-06-13       Impact factor: 3.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.